Old Web
English
Sign In
Acemap
>
authorDetail
>
NigelP. Jones
NigelP. Jones
GlaxoSmithKline
Endocrinology
Internal medicine
Diabetes mellitus
Rosiglitazone
Medicine
5
Papers
107
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes.
2003
Diabetes, Obesity and Metabolism
T. A. Jones
M. Sautter
L. Van Gaal
NigelP. Jones
Show All
Source
Cite
Save
Citations (94)
Rosiglitazone: Long-term efficacy in combination with metformin or as monotherapy
2000
Diabetes Research and Clinical Practice
NigelP. Jones
RichardA. Mather
Stuart Owen
RitaN. Patwardhan
Show All
Source
Cite
Save
Citations (3)
Rosiglitazone increases insulin sensitivity and reduces factors associated with insulin resistance in type 2 diabetics
2000
Diabetes Research and Clinical Practice
DavidG. Carey
GaryJ. Cowin
GrahamJ. Galloway
DavidM. Doddrell
JacquelineC. Richards
NigelP. Jones
Nandita Biswas
Show All
Source
Cite
Save
Citations (8)
Proinsulin/insulin ratio reduced and β-cell function improved in type 2 diabetes with rosiglitazone
2000
Diabetes Research and Clinical Practice
Steven E. Kahn
MartinI. Freed
LisaE. Porter
NigelP. Jones
Nandita Biswas
Show All
Source
Cite
Save
Citations (2)
Rosiglitazone: Effective when added to metformin in obese, insulin-resistant patients with type 2 diabetes
2000
Diabetes Research and Clinical Practice
TraceyA. Jones
NigelP. Jones
MaureenC. Sautter
Show All
Source
Cite
Save
Citations (0)
1